Process vs. Material Origins Nitrosamine impurities originate from active pharmaceutical ingredient (API) synthetic pathways, degraded raw materials, or chemical interactions […]
What Is the Difference Between a Nitrosamine Impurity and a Nitrosamine Leachable? Read More »
Maintaining a predictable Nitrosamine Testing Timeline has become a critical operational requirement for pharmaceutical manufacturers working to meet stringent compliance
How Long Does Nitrosamine Testing Take? Realistic Timelines by Study Type Read More »
Introduction: Why a Single Nitrosamine Testing Panel Is Insufficient for Cardiac Drug Classes Understanding drug-class-specific nitrosamine chemistry is one of
Introduction: Pharmaceutical manufacturers function under rigorous oversight from major global regulatory agencies, including the United States Food and Drug Administration
Outsourcing Nitrosamine Testing to a CRO: Scope of Work, Timeline, and Cost Expectations Read More »
Introduction: Why Nitrosamines Require a Distinct Focus Within ICH M7 Genotoxic Impurity Testing When ICH M7 was finalized in 2014,
Genotoxic Impurity Testing: Where Nitrosamines Fit Within the Broader ICH M7 Framework Read More »
Introduction to Nitrosamine Lifecycle Management Nitrosamine Lifecycle Management is essential for maintaining effective control of nitrosamine impurities after pharmaceutical products
Lifecycle Management of Nitrosamine Control Strategies Post-Approval Read More »
Introduction The Nitrosamine Risk in Solid vs Liquid Dosage forms has become a critical topic in pharmaceutical quality and regulatory
Nitrosamine Risk in Solid Oral Dosage vs Liquid Formulations: Comparative Analysis Read More »
Introduction Nitrosamine Testing for OTC Products demands a risk-based and stability-focused approach that goes beyond traditional impurity testing. Over-the-counter medicines
Nitrosamine Testing for Over-the-Counter (OTC) Products: Special Considerations Read More »
Introduction: The Nitrosamine Batch Release Testing Requirement becomes mandatory when confirmatory testing shows nitrosamine impurity levels above 10% of the
Nitrosamine Batch Release Testing: When Is Routine Testing Required? Read More »
Introduction: Why Nitrosamine Testing Highly Potent APIs Requires Specialized Expertise Nitrosamine Testing Highly Potent APIs demands highly sensitive analytical methods,
Nitrosamine Testing in Controlled Substances and Highly Potent APIs (HPAPIs) Read More »
